PharmiNews

Directory of Pharma Companies and News

Company Profile

NovaBiotics

NovaBiotics logo
Category
NovaBiotics Ltd is a clinical-stage biotechnology company focused on the design and development of first-in-class therapies for difficult-to-treat, medically unmet infectious diseases caused by bacteria and fungi and respiratory conditions including cystic fibrosis. A leading innovator in the anti-infectives space, the Company’s robust technology and business model has been validated through successful development, from concept to late stage clinical development, of its most advanced product candidates. In addition to the lead NM002 Nylexa programme and the Company’s other late-stage assets (NM001/Lynovex® for cystic fibrosis, NP213/Novexatin® for onychomycosis), NovaBiotics has generated a robust pipeline of earlier stage, high-value drug candidates including NP339 (Department of Health and Social Care funded programme) for life threatening, drug resistant invasive fungal disease and NP432 for multi-drug resistant bacterial infections.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma